Literature DB >> 15226053

Distress after an abnormal Pap smear result: scale development and psychometric validation.

Eileen Shinn1, Karen Basen-Engquist, Tao Le, Andrea Hansis-Diarte, De'Shaunda Bostic, Jodi Martinez-Cross, Annette Santos, Michele Follen.   

Abstract

BACKGROUND: Psychological distress is severe in women who receive a report of abnormal findings on Pap smear, and may be one reason 10-61% of such women fail to undergo follow-up testing.
METHODS: Using the 14-question Psychosocial Effects of Abnormal Pap Smears Questionnaire (PEAPS-Q) as a basis, we developed the 23-question Cervical Dysplasia Distress Questionnaire (CDDQ), testing its internal consistency and validity with 661 women undergoing colposcopy after an abnormal Pap smear finding in a three-phase analysis.
RESULTS: Items were divided into two sets and factor analyzed separately: one addressed distress during medical procedures, and the other concerned perceived consequences of an abnormal Pap smear. The medical procedures items yielded two factors: embarrassment regarding the procedures and discomfort/tension with the procedures. Factor analysis of the second set also resulted in two factors: concern about sexual and reproductive issues and concern about health consequences. Subscales created from items loading highly on each factor had high internal consistency (alpha ranged from 0.76 to 0.90) and demonstrated good concurrent validity with other psychometrically validated measures of distress.
CONCLUSIONS: The CDDQ is a reliable and valid questionnaire for measuring multiple domains of distress unique to women who test positive on a cervical cancer screening test.

Entities:  

Mesh:

Year:  2004        PMID: 15226053     DOI: 10.1016/j.ypmed.2004.02.004

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  19 in total

1.  A new self-report measure of self-management of type 1 diabetes for adolescents.

Authors:  Lynne S Schilling; Jane K Dixon; Kathleen A Knafl; Mary R Lynn; Kathryn Murphy; Susan Dumser; Margaret Grey
Journal:  Nurs Res       Date:  2009 Jul-Aug       Impact factor: 2.381

2.  Optical technologies and molecular imaging for cervical neoplasia: a program project update.

Authors:  Timon P H Buys; Scott B Cantor; Martial Guillaud; Karen Adler-Storthz; Dennis D Cox; Clement Okolo; Oyedunni Arulogon; Oladimeji Oladepo; Karen Basen-Engquist; Eileen Shinn; José-Miguel Yamal; J Robert Beck; Michael E Scheurer; Dirk van Niekerk; Anais Malpica; Jasenka Matisic; Gregg Staerkel; Edward Neely Atkinson; Luc Bidaut; Pierre Lane; J Lou Benedet; Dianne Miller; Tom Ehlen; Roderick Price; Isaac F Adewole; Calum MacAulay; Michele Follen
Journal:  Gend Med       Date:  2011-09-22

3.  Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study.

Authors:  Eileen Shinn; Usman Qazi; Shalini Gera; Joan Brodovsky; Jessica Simpson; Michele Follen; Karen Basen-Engquist; Calum Macaulay
Journal:  Gend Med       Date:  2012-02

Review 4.  Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  The likelihood of participation in clinical trials can be measured: the Clinical Research Involvement Scales.

Authors:  Paula M Frew; Su-I Hou; Marsha Davis; Kayshin Chan; Takeia Horton; Justin Shuster; Brooke Hixson; Carlos del Rio
Journal:  J Clin Epidemiol       Date:  2010-03-19       Impact factor: 6.437

6.  Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study.

Authors:  Linda A Liang; Sylke R Zeissig; Gunther Schauberger; Sophie Merzweiler; Kathrin Radde; Sabine Fischbeck; Hans Ikenberg; Maria Blettner; Stefanie J Klug
Journal:  BMC Womens Health       Date:  2022-07-09       Impact factor: 2.742

7.  Factors Associated With Adherence to Follow-up Colposcopy.

Authors:  Laura J Fish; Patricia G Moorman; Lashawn Wordlaw-Stintson; Adriana Vidal; Jennifer S Smith; Cathrine Hoyo
Journal:  Am J Health Educ       Date:  2013

8.  Application of Raman spectroscopy for cervical dysplasia diagnosis.

Authors:  Elizabeth M Kanter; Elizabeth Vargis; Shovan Majumder; Matthew D Keller; Emily Woeste; Gautam G Rao; Anita Mahadevan-Jansen
Journal:  J Biophotonics       Date:  2009-02       Impact factor: 3.207

9.  Intervention to improve follow-up for abnormal Papanicolaou tests: a randomized clinical trial.

Authors:  Carmen Radecki Breitkopf; Lauren Dawson; James J Grady; Daniel M Breitkopf; Carolyn Nelson-Becker; Russell R Snyder
Journal:  Health Psychol       Date:  2013-06-03       Impact factor: 4.267

10.  Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States.

Authors:  Harrell W Chesson; Elaine W Flagg; Laura Koutsky; Katherine Hsu; Elizabeth R Unger; Judith C Shlay; Peter Kerndt; Khalil G Ghanem; Jonathan M Zenilman; Michael Hagensee; Hillard Weinstock; S Deblina Datta
Journal:  Vaccine       Date:  2013-05-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.